Category: HIV/AIDS

National AIDS Council, City Fathers Hold Indaba to Tackle Emerging Vices Driving HIV Risk

Michael Gwarisa

By Michael Gwarisa in Mazowe The National AIDS Council convened a one day sensitisation indaba with councillors from the City of Harare in Mazowe, Mashonaland Central, as part of efforts to strengthen the HIV and AIDS response amid emerging social and health challenges. The meeting brought together city fathers, government officials and health stakeholders to deliberate on issues increasingly complicating the HIV response, including non communicable diseases, drug and substance abuse, and rising new infections among young people and key populations. Officiating at the indaba, the Minister of State for…

Read More

When Santa Brings Joy at Christmas, Injiva Bring Infections and Unintended Pregnancies: The Hidden HIV Threat Facing Mat South Girls

Michael Gwarisa

By Michael Gwarisa in Mat South In most parts of Matabeleland South, the festive season does not only bring tinsel and holiday cheer. It brings something far more complicated. Bottle store owners and shopkeepers prepare for football tournaments that turn their businesses into instant profit zones, while a quieter and more vulnerable anticipation grows among young girls in the villages. They know the Injiva are coming. These are men returning from South Africa or Botswana with cash in hand and the confidence to spend it. For many girls, the homecoming…

Read More

An HIV Wave Hitting Only One Side of the Market: Women in Mat South Are Bearing the Brunt

Michael Gwarisa

By Michael Gwarisa in Mat South In Matabeleland South, the burden of new HIV infections falls almost exclusively on women. The numbers are more than statistics; they depict a crisis where mothers and daughters are diagnosed one after the other, while men’s rates lag behind. This imbalance is shrinking families, disrupting livelihoods, and leaving communities to pick up the pieces. Data from the 2022 National Housing and Population Census shows that Matabeleland South has an estimated population of 760,000 people. Of these, the National AIDS Council (NAC) estimates that 93,000…

Read More

Zimbabwe’s Medicines Regulatory Body Registers Lencapavir

Michael Gwarisa

By Michael Gwarisa The Medicines Control Authority of Zimbabwe (MCAZ) has announced the expedited approval of Lenacapavir, an innovative long-acting medicine for pre exposure prophylaxis (PrEP) to prevent HIV-1 infection. The MCAZ Director-General, Mr. Richard T. Rukwata, said “the rapid approval of Lenacapavir reflects the Authority’s dedication to accelerating access to trusted, high-quality health products and brings new hope for HIV prevention while reinforcing its commitment to safeguarding public health.” Lenacapavir was assessed and approved by the Registration Committee under the expedited review process, as it is considered to be…

Read More

High Demand Pushes America to Increase Lenacapavir Supply as Eswatini Gets First Shipment

Michael Gwarisa

By Michael Gwarisa The Kingdom of Eswatini has received its first shipment of the lifesaving HIV prevention drug Lenacapavir, a few months after becoming one of the few  African countries earmarked for the rollout to take delivery. The twice-a-year injectable drug will be introduced under the America First Global Health Strategy, which guides the United States’ global health programming across the continent. Launched in September, the America First Global Health Strategy aims to shift the United States’ global health efforts toward strengthening African health systems and building market-driven partnerships. Under…

Read More

Zimbabwe to Prioritise Local Funding in New HIV Strategy

Michael Gwarisa

By Michael Gwarisa Zimbabwe is set to begin developing its fifth Zimbabwe National HIV and AIDS Strategic Plan (ZNASP V), which will guide the country’s HIV response from 2026 to 2030. The forthcoming strategy follows the successful implementation of ZNASP IV, which runs until 2025 and has seen major progress in the fight against HIV. Under ZNASP IV, Zimbabwe achieved remarkable milestones, including meeting the global 95-95-95 targets — where 95% of people living with HIV know their status, 95% of those diagnosed are on treatment, and 95% of those…

Read More

US Unveils $65 Million Bridge Plan to Sustain Zimbabwe’s HIV Respons

Michael Gwarisa

By Michael Gwarisa The United States Department of State, through the President’s Emergency Plan for AIDS Relief (PEPFAR), has unveiled a new HIV and AIDS support fund worth US$65.1 million for Zimbabwe. The initiative, known as The Bridge Plan, will run for the next six months, with renewal contingent on the Government of Zimbabwe meeting new U.S. Government (USG) funding requirements. Under the Bridge Plan, the U.S. government will continue to support critical HIV interventions such as antiretroviral therapy (ART) and HIV commodities procurement. However, the new funding excludes certain…

Read More

NAC Hands Over Blood and Renal Units to Parirenyatwa Hospital

Michael Gwarisa

By Michael Gwarisa The National AIDS Council (NAC) has officially handed over two critical health projects, a Family Blood Bank and a Renal Diagnostic Unit, to the Ministry of Health and Child Care (MoHCC) at Parirenyatwa Group of Hospitals, in a move set to boost the quality of healthcare services in Zimbabwe. Speaking at the handover ceremony on Tuesday, NAC Chief Executive Officer Dr. Bernard Madzima said the new facilities represent NAC’s commitment to strengthening the country’s health system beyond the HIV and AIDS response. We are gathered here to…

Read More

United Nations Proposes Shutting Down UNAIDS In 2026

Michael Gwarisa

By Staff Reporter  The United Nations (UN) agency focusing on the HIV/AIDS pandemic could close by the end of next year as the UN restructures in the face of a funding crisis, according to a UN document published online. UNAIDS will “sunset” by the end of 2026, the document published on Thursday reads, part of a set of proposals from the UN to member states which they will have to decide on. It adds that UNAIDS’ expertise should be shifted into the wider UN system in the following year. The…

Read More

Zimbabwe Selected Among Ten Countries to Roll Out Breakthrough HIV Prevention Drug, Lenacapavir

Michael Gwarisa

By Michael Gwarisa  Zimbabwe has been selected as one of ten countries globally to roll out lenacapavir, a revolutionary new HIV prevention drug that is being hailed as a game-changer in the global fight against HIV. The announcement was made on the official U.S. Embassy Zimbabwe Facebook page, marking a historic milestone in the country’s decades-long battle to curb new HIV infections. Lenacapavir, developed by U.S.-based Gilead Sciences in partnership with the Global Fund, is the world’s first twice-yearly HIV prevention medicine. Clinical trial data shows that more than 99%…

Read More